An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: Preliminary results on tolerability and clinical effects

Annals of General Psychiatry

Volumn 10, Issue , 2011, Pages

  Fornaro, Michele ^a   Martino, Matteo ^a   Dalmasso, Bruna ^a   Colicchio, Salvatore ^b   Benvenuti, Marzia ^c   Rocchi, Giulio ^a   Escelsior, Andrea ^a   Perugi, Giulio ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; ZONISAMIDE;

ADD ON THERAPY; ADULT; ANORGASMIA; ARIZONA SEXUAL EXPERIENCE SCALE; ARTICLE; BLURRED VISION; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEARING DISORDER; HUMAN; HYPERPHAGIA; HYPERSOMNIA; INSOMNIA; LIBIDO DISORDER; LOW DRUG DOSE; MAJOR DEPRESSION; MALAISE; MALE; MICTURITION DISORDER; MONOTHERAPY; OPEN STUDY; PATIENT RATED INVENTORY OF SIDE EFFECTS; PILOT STUDY; POLLAKISURIA; RATING SCALE; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; YOUNG MANIA RATING SCALE;

EID: 80052831079     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-10-23     Document Type: Article

References (26)

1. Tylee A, Walters P. The burden of depression. Hosp Med 2002, 63:580-581.
2. Fornaro M, Giosue P. Current nosology of treatment resistant depression: a controversy resistant to revision. Clin Pract Epidemiol Ment Health 2010, 6:20-24. 10.2174/1745017901006010020, 2887642, 20563286.
3. Fava M. Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry 2001, 62(Suppl 18):4-11.
4. Petersen T, Perlis RH, Ticknor C, Lohr J, Solvason HB, O'Reardon JP, Wohlreich MM, Andreotti C, Wilson M, Fava M. Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Psychopharmacol Bull 2008, 41:34-45.
5. Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 2007, 27:263-272. 10.1097/jcp.0b013e318059361a, 17502773.
6. Feiner NF. Antiepileptic drug augmentation for treatment-resistant depression. J Clin Psychiatry 1997, 58:361-363.
7. Janati A, Shneker BF, Cios JS, Elliott JO. Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert. Neurology 2009, 73:1710. 10.1212/WNL.0b013e3181bd6bd4, 19917998.
8. Wen X, Meador KJ, Loring DW, Eisenschenk S, Segal R, Hartzema AG. Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?. Epilepsy Behav 2010, 19:494-500. 10.1016/j.yebeh.2010.08.030, 20880757.
9. Thomas SP, Nandhra HS, Jayaraman A. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Ment Health 2010, 19:168-175. 10.3109/09638230903469269, 20433324.
10. American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders 1994, Washington, DC: American Psychiatric Association, Fourth, American Psychiatric Association.
11. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992, 13:107-112. 10.1016/0920-1211(92)90065-2, 1334455.
12. Lang DG, Wang CM, Cooper BR. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 1993, 266:829-835.
13. White HS. Mechanism of action of newer anticonvulsants. J Clin Psychiatry 2003, 64(Suppl 8):5-8.
14. Okada M, Kaneko S, Hirano T, Mizuno K, Kondo T, Otani K, Fukushima Y. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995, 22:193-205. 10.1016/0920-1211(95)00078-X, 8991786.
15. Okada M, Hirano T, Kawata Y, Murakami T, Wada K, Mizuno K, Kondo T, Kaneko S. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res 1999, 34:187-197. 10.1016/S0920-1211(98)00109-0, 10210034.
16. Sobieszek G, Borowicz KK, Kimber-Trojnar Z, Malek R, Piskorska B, Czuczwar SJ. Zonisamide: a new antiepileptic drug. Pol J Pharmacol 2003, 55:683-689.
17. Kinrys G, Vasconcelos e Sa D, Nery F. Adjunctive zonisamide for treatment refractory anxiety. Int J Clin Pract 2007, 61:1050-1053. 10.1111/j.1742-1241.2007.01365.x, 17504366.
18. Murata M. Zonisamide: a new drug for Parkinson's disease. Drugs Today (Barc) 2010, 46:251-258.
19. Kaneko S, Okada M, Hirano T, Kondo T, Otani K, Fukushima Y. Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Jpn J Psychiatry Neurol 1993, 47:371-373.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
21. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 1998, 79:163-173. 10.1016/S0165-1781(98)00038-9, 9705054.
22. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55. 10.1111/j.2044-8341.1959.tb00467.x, 13638508.
23. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435. 10.1192/bjp.133.5.429, 728692.
24. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000, 26:25-40. 10.1080/009262300278623, 10693114.
25. STAR*D Project Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. STAR*D Project., http://www.edc.pitt.edu/stard/public/assessment_forms.html
26. Preskorn SH. Results of the STAR*D study: implications for clinicians and drug developers. J Psychiatr Pract 2009, 15:45-49. 10.1097/01.pra.0000344918.51404.1e, 19182564.